Shanghai Pharmaceuticals Holding Co Ltd Class H 02607
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$11.08
- Day Range
- HK$10.70–11.13
- 52-Week Range
- HK$10.70–12.46
- Bid/Ask
- HK$10.83 / HK$10.84
- Shares Outstanding
- 3.71B
- Market Cap
- HK$40.20B
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 9.89
- Price/Sales
- 0.13
- Dividend Yield (Trailing)
- 4.71%
- Dividend Yield (Forward)
- 4.71%
- Dividend Payment Schedule
- Feb, Aug
- Total Yield
- 4.71%
Company Profile
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Large Value
- Total Number of Employees
- 49,608
- Website
- https://www.sphchina.com
Valuation
|
Metric
|
02607
|
|---|---|
Price/Earnings (Normalized) | 9.89 |
Price/Book Value | 0.45 |
Price/Sales | 0.13 |
Price/Cash Flow | 3.45 |
Price/Earnings
02607
Financial Strength
|
Metric
|
02607
|
|---|---|
Quick Ratio | 1.02 |
Current Ratio | 1.34 |
Interest Coverage | 6.53 |
Quick Ratio
02607
Profitability
|
Metric
|
02607
|
|---|---|
Return on Assets (Normalized) | 1.41% |
Return on Equity (Normalized) | 4.39% |
Return on Invested Capital (Normalized) | 2.94% |
Return on Assets
02607
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|!kv&f@ | LOCK|!z!t | $105B | |||
| Cencora Inc
COR
| LOCK|>tJXC&^ | LOCK|C<mc! | $59B | |||
| Cardinal Health Inc
CAH
| LOCK|SYj@F@ | LOCK|^F?@ | $53B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|lQz@L | $21B | |||
| Henry Schein Inc
HSIC
| LOCK|!%?L!#! | LOCK|^ztpl | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|?< | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|#$ | $6B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|W# | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|l&!V | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|xm | $4B |
United States